J.W. Burns & Co’s TherapeuticsMD TXMD Stock Holding History

J.W. Burns & Co’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-298	Closed	-$107K	–	161
2017 Q1	$107K	Sell	298 -10	-3%	-$3.1K	0.03%	158
2016 Q4	$89K	Sell	308 -110	-26%	-$34.1K	0.03%	153
2016 Q3	$142K	Sell	418 -88	-17%	-$32.1K	0.04%	150
2016 Q2	$215K	Buy	+506	New	+$209K	0.07%	145
2015 Q3	–	Sell	-219	Closed	-$86K	–	155
2015 Q2	$86K	Buy	+219	New	+$77.3K	0.03%	152
2015 Q1	–	Sell	-259	Closed	-$58K	–	157
2014 Q4	$58K	Sell	259 -461	-64%	-$95.1K	0.02%	154
2014 Q3	$167K	Hold	720	–	–	0.06%	153
2014 Q2	$159K	Sell	720 -337	-32%	-$75K	0.05%	157
2014 Q1	$333K	Buy	1,057 +828	+362%	+$264K	0.12%	126
2013 Q4	$60K	Buy	+229	New	+$50.1K	0.02%	153

Other funds holding TXMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

J.W. Burns & Co's TXMD Position: Q2 2017 in Review

J.W. Burns & Co sold out of TherapeuticsMD (TXMD) in Q2 2017, closing a stake of 298 shares — an estimated $107K sold.

J.W. Burns & Co first reported a position in TXMD in Q4 2013 and held it in 10 quarters. The position peaked at $333K in Q1 2014. 117 funds tracked by Wall St. Rank hold TXMD as of Q2 2017.

J.W. Burns & Co reported no remaining TherapeuticsMD position as of Q2 2017 after selling out during the quarter.
J.W. Burns & Co sold 298 TherapeuticsMD shares in Q2 2017, an estimated $107K.
J.W. Burns & Co first reported a position in TherapeuticsMD in Q4 2013 and held it in 10 quarters.
J.W. Burns & Co's TherapeuticsMD position peaked at $333K in Q1 2014.
117 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2017.

Based on J.W. Burns & Co's 13F filing for Q2 2017, filed 7 Jul 2017.